Literature DB >> 29900399

The effect of synbiotics Bifidobacterium infantis and milk oligosaccharides on shaping gut microbiota community structure and NASH treatment.

Prasant Kumar Jena1, Lili Sheng1, Nidhi Nagar1, Chao Wu2, Daniela Barile3, David A Mills3,4, Yui-Jui Yvonne Wan1.   

Abstract

Probiotic Bifidobacterium longum subspecies infantis (Bifidobacterium infantis) consumes human milk oligosaccharides (MO) and protects intestinal permeability thereby having anti-inflammatory effects (Underwood et al., 2015; Bode, 2006; Asakuma et al., 2011) [1-3]. Via the gut-liver axis, gut barrier disruption and dysbiosis lead to hepatic inflammation (Sheng et al., 2017; Jena et al., 2017) [4,5,6]. Our published data revealed that butyrate, as well as synbiotics of B. infantis in combination with MO, had protective effects against cancer-prone non-alcoholic steatohepatitis (NASH) mouse models, i.e., Western diet (WD)-fed bile acid receptor FXR (farnesoid x receptor) knockout (KO) mice (Jena et al., 2018) [6,7]. In addition, MO was particularly effective in increasing the blooming of butyrate-generating bacteria (Jena et al., 2018) [7]. In the present study, we further showed that the reduced ileal short chain fatty acid (SCFA) signaling found in WD-fed FXR KO mice could be reversed by B. infantis and/or MO treatment. Moreover, ileal mRNA levels of SCFA receptors i.e. Gpr41 (Ffar3), Gpr109 (Hcar2), and Gpr43 (Ffar2) were increased in B. infantis and/or MO-treated mice suggesting increased SCFA signaling (Fig. 1). Further, nuclear magnetic resonance (NMR) data revealed that MO and B. Infantis plus MO increased intestinal acetate, propionate, butyrate, and valerate levels (Fig. 2). In addition, B. infantis and/or MO reduced the abundance of genus Bilophila and the relative copy number of bacterial genes including dissimilatory sulfite reductase (dsrA) and methyl coenzyme M reductase A (mcrA), which were all increased in cancer-prone FXR KO mice (Fig. 3).

Entities:  

Keywords:  Inflammation; Probiotics; Short chain fatty acid; Western diet

Year:  2018        PMID: 29900399      PMCID: PMC5997954          DOI: 10.1016/j.dib.2018.05.127

Source DB:  PubMed          Journal:  Data Brief        ISSN: 2352-3409


Specifications Table Value of the data In our earlier report, B. infantis and MO treatment reduced hepatic and ileal inflammation [7]. It has been shown that B. infantis and MO protects from gut barrier function and inflammation [1], [2], [3]. In addition, the abundance of bacterial butyrate-generating genes bcoA (butyryl-CoA: acetate CoA-transferase) and buk (butyrate kinase) in the cecum was increased with MO and B. infantis plus MO treatment. Data in this study described the mRNA expression of SCFA receptors regulated by B. infantis and MO treatment. Our data showed that increased SCFA signaling with B. infantis and MO treatment was associated with reduced inflammation. In our earlier report, the concentration of butyrate was reduced in FXR KO mice [6]. Data in this study described that B. infantis and MO increased SCFAs, i.e., acetate, propionate, butyrate, and valerate. Additionally, such increases were accompanied by reduced inflammation in FXR KO mice. It has been shown that dysregulated bile acid and gut dysbiosis causes hepatic inflammation [4], [5], [6], [7]. Moreover, the abundance of genus Bilophila and dsrA gene, which are involved in the generation of hydrogen sulfide, was increased by FXR inactivation and B. infantis and MO treatment reversed those changes. These data suggested that the anti-inflammatory effect of B. infantis and MO may due to increased SCFAs and reduced hydrogen sulfide and methane.

Data

The data showed the mRNA level of ileal SCFA receptors i.e. Gpr41, Gpr109a, and Gpr43 in WD-fed wild type (WT) mice and WD-fed FXR KO mice supplemented with or without Bifidobacterium infantis and/or MO (Fig. 1). NMR data generated from cecal content showed the concentration of acetate, propionate, butyrate, and valerate (Fig. 2). Moreover, bacteria and their functional genes were determined by real-time quantitative PCR (Fig. 3).
Fig. 1

The effects of B. infantis and/or MO on SCFA receptor signaling. Ileal mRNA level of indicated genes in WD-fed WT mice and WD-fed FXR KO mice supplemented with and without B. infantis and/or MO for 7 months. Data expressed as mean ± SD. n ≥ 6 per group. *p< 0.05, **p< 0.01. WT mice compared with FXR KO mice, and untreated FXR KO mice compared with treated FXR KO mice on the same diet.

Fig. 2

NMR analysis of SCFA concentration in cecal content of WD-fed WT mice and WD-fed FXR KO mice treated with and without B. infantis and/or MO. Data expressed as mean±SD. n ≥ 6 per group. *p< 0.05. WT mice compared with FXR KO mice, and untreated FXR KO mice compared with treated FXR KO mice.

Fig. 3

Targeted functional quantitative PCR analyses of microbial genes in WD-fed WT mice and WD-fed FXR KO mice supplemented with and without B. infantis and/or MO. Data expressed as mean±SD. n ≥ 6 per group. *p< 0.05, **p< 0.01, ***p< 0.001, WT mice compared with FXR KO mice, and untreated FXR KO mice compared with treated FXR KO mice.

The effects of B. infantis and/or MO on SCFA receptor signaling. Ileal mRNA level of indicated genes in WD-fed WT mice and WD-fed FXR KO mice supplemented with and without B. infantis and/or MO for 7 months. Data expressed as mean ± SD. n ≥ 6 per group. *p< 0.05, **p< 0.01. WT mice compared with FXR KO mice, and untreated FXR KO mice compared with treated FXR KO mice on the same diet. NMR analysis of SCFA concentration in cecal content of WD-fed WT mice and WD-fed FXR KO mice treated with and without B. infantis and/or MO. Data expressed as mean±SD. n ≥ 6 per group. *p< 0.05. WT mice compared with FXR KO mice, and untreated FXR KO mice compared with treated FXR KO mice. Targeted functional quantitative PCR analyses of microbial genes in WD-fed WT mice and WD-fed FXR KO mice supplemented with and without B. infantis and/or MO. Data expressed as mean±SD. n ≥ 6 per group. *p< 0.05, **p< 0.01, ***p< 0.001, WT mice compared with FXR KO mice, and untreated FXR KO mice compared with treated FXR KO mice.

Experimental design

Mice

Specific pathogen-free male C57BL/6 WT mice (Jackson Laboratory, Sacramento, CA, USA) and FXR KO mice were housed in steel microisolator cages at 22 °C with a 12-h light/dark cycle. They were given a WD containing 21.2% fat, 34% sucrose, and 0.2% cholesterol (Envigo, Indianapolis, IN, USA) right after weaning (3 weeks, 6–10 mice per group). When mice were 3-month old, they were given B. infantis (109 cfu per mouse, orally, once a week) in saline, bovine MO (7% in a diet that lacks 7% cellulose), or a combination of B. infantis plus MO while mice continued a WD until they were 10-month old. Experiments were conducted in accordance with the National Institutes of Health Guidelines for the Care and Use of Laboratory Animals under protocols approved by the Institutional Animal Care and Use Committee of the University of California, Davis.

Gene expression and quantification of bacterial genes

RNA was isolated from mouse tissues using TRIzol (Invitrogen, Carlsbad, CA, USA) and reverse transcribed into cDNA. qRT-PCR was performed on an ABI 7900HT Fast real-time PCR system using Power SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA, USA). The mRNA levels were normalized to the level of Gapdh mRNA. The primer sets used are described in Table 1.
Table 1

Primers used for qPCR.

GeneForward (5’ – 3’)Reverse (5’ – 3’)
qPCR primers used to quantify gene expression in mice
Gpr41GTGACCATGGGGACAAGCTTCCCCTGGCTGTAGGTTGCATT
Gpr109aATGGCGAGGCATATCTGTGTAGCATCCTGCCTGAGCAGAACAAGATGA
Gpr43GGCTTCTACAGCAGCATCTAAAGCACACCAGGAAATTAAG
qPCR primers used to quantify bacterial genes
Bilophila (tpA)CGGTATCGAAATCGTGAAGGCAGAGGGTCAGGGTGTTGTT
dsrAGCCGTTACTGTGACCAGCCGGTGGAGCCGTGCATGTT
mcrATTCGGTGGATCDCARAGRGCGBARGTCGWAWCCGTAGAATCC
Primers used for qPCR. For bacterial gene quantification, cecal (0.05 g) DNA was extracted using ZR Fecal DNA MiniPrep Kit (Zymo Research, Irvine, CA, USA), quantified by NanoDrop (Thermo Scientific, Wilmington, DE, USA), and amplified using primers listed in Table 1. A dissociation step was included to analyze the melting profile of amplified products. In parallel, qPCR was performed using ten-fold serial diluted synthetic DNA fragments (Integrative DNA technologies, Redwood city, CA, USA) of a bacterial gene with known concentrations. Bacterial DNA concentration was calculated using standard curves of diluted synthetic DNA fragment based on method described elsewhere [8].

1H NMR spectroscopy for metabolic profiling

Cecal samples (50−60 mg) were prepared and analyzed by 1H NMR based on published method [6], [9]. Each cecal sample was homogenized and mixed with sodium-potassium phosphate buffer and centrifuged at 14,000g for 20 min. All 1H NMR spectra were collected using a Bruker advance 600 NMR spectrometer (Bruker; Rheinstetten, Germany). The samples were pre-cooled to 277 K before being loaded into the magnet, and were warmed to 298 K and equilibrated for 5 min before data acquisition. For each sample, 64 scans were collected into 64 K data points over a spectral width of 20 ppm with a relaxation delay of 2 s. Identification and quantification of metabolites were accomplished using Chenomx NMR Suite 7.6 (Chenomx, Inc., Edmonton, Alberta, Canada).

Statistical analysis

Data are presented as the mean ± SD. Statistical analysis was performed by unpaired Student׳s t-test or one-way analysis of variance by using GraphPad Prism 6.0 (GraphPad, La Jolla, CA, USA). P < 0.05 was considered statistically significant.
Subject areaBiology, Microbiology, Molecular Biology
More specific subject areaSynbiotics
Type of dataTable, figure, graph
How data was acquiredReal time PCR, NMR
Data formatAnalyzed
Experimental factorsC57BL/6 wild type and FXR KO male mice were fed with Western diet after weaning. When mice were 3-month old, they were given B. infantis (109cfu per mouse, orally, once a week) in saline, bovine MO (7% in a diet that lacks 7% cellulose), or a combination of B. infantis plus MO while mice continued a WD for 7 months and euthanized when they were 10-month old.
Experimental featuresGene expression in ileum and SCFA concentration in cecal content were measured by real time PCR and NMR, respectively.
Data source locationSacramento, California, United States of America
Data accessibilityData with this article
  9 in total

1.  Physiology of consumption of human milk oligosaccharides by infant gut-associated bifidobacteria.

Authors:  Sadaki Asakuma; Emi Hatakeyama; Tadasu Urashima; Erina Yoshida; Takane Katayama; Kenji Yamamoto; Hidehiko Kumagai; Hisashi Ashida; Junko Hirose; Motomitsu Kitaoka
Journal:  J Biol Chem       Date:  2011-08-09       Impact factor: 5.157

2.  Western Diet-Induced Dysbiosis in Farnesoid X Receptor Knockout Mice Causes Persistent Hepatic Inflammation after Antibiotic Treatment.

Authors:  Prasant K Jena; Lili Sheng; Hui-Xin Liu; Karen M Kalanetra; Annie Mirsoian; William J Murphy; Samuel W French; Viswanathan V Krishnan; David A Mills; Yu-Jui Yvonne Wan
Journal:  Am J Pathol       Date:  2017-07-12       Impact factor: 4.307

3.  Synbiotics Bifidobacterium infantis and milk oligosaccharides are effective in reversing cancer-prone nonalcoholic steatohepatitis using western diet-fed FXR knockout mouse models.

Authors:  Prasant Kumar Jena; Lili Sheng; Nidhi Nagar; Chao Wu; Daniela Barile; David A Mills; Yui-Jui Yvonne Wan
Journal:  J Nutr Biochem       Date:  2018-04-25       Impact factor: 6.048

4.  Age-related topographical metabolic signatures for the rat gastrointestinal contents.

Authors:  Yuan Tian; Limin Zhang; Yulan Wang; Huiru Tang
Journal:  J Proteome Res       Date:  2011-12-27       Impact factor: 4.466

Review 5.  Recent advances on structure, metabolism, and function of human milk oligosaccharides.

Authors:  Lars Bode
Journal:  J Nutr       Date:  2006-08       Impact factor: 4.798

6.  Diet, microbiota, and microbial metabolites in colon cancer risk in rural Africans and African Americans.

Authors:  Junhai Ou; Franck Carbonero; Erwin G Zoetendal; James P DeLany; Mei Wang; Keith Newton; H Rex Gaskins; Stephen J D O'Keefe
Journal:  Am J Clin Nutr       Date:  2013-05-29       Impact factor: 7.045

7.  Hepatic inflammation caused by dysregulated bile acid synthesis is reversible by butyrate supplementation.

Authors:  Lili Sheng; Prasant Kumar Jena; Ying Hu; Hui-Xin Liu; Nidhi Nagar; Karen M Kalanetra; Samuel William French; Samuel Wheeler French; David A Mills; Yu-Jui Yvonne Wan
Journal:  J Pathol       Date:  2017-11-01       Impact factor: 7.996

Review 8.  Bifidobacterium longum subspecies infantis: champion colonizer of the infant gut.

Authors:  Mark A Underwood; J Bruce German; Carlito B Lebrilla; David A Mills
Journal:  Pediatr Res       Date:  2014-10-10       Impact factor: 3.756

9.  Gender Differences in Bile Acids and Microbiota in Relationship with Gender Dissimilarity in Steatosis Induced by Diet and FXR Inactivation.

Authors:  Lili Sheng; Prasant Kumar Jena; Hui-Xin Liu; Karen M Kalanetra; Frank J Gonzalez; Samuel W French; Viswanathan V Krishnan; David A Mills; Yu-Jui Yvonne Wan
Journal:  Sci Rep       Date:  2017-05-11       Impact factor: 4.379

  9 in total
  1 in total

1.  Probiotics VSL#3 are effective in reversing non-alcoholic steatohepatitis in a mouse model.

Authors:  Prasant Kumar Jena; Lili Sheng; Yongchun Li; Yui-Jui Yvonne Wan
Journal:  Hepatobiliary Surg Nutr       Date:  2020-04       Impact factor: 7.293

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.